Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.

MLA

Romiti, Giulio Francesco, et al. “Prevalence, Management and Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,200,000 Patients.” European Heart Journal, vol. 42, no. 35, Sept. 2021, pp. 3541–54. EBSCOhost, https://doi.org/10.1093/eurheartj/ehab453.

APA

Romiti, G. F., Corica, B., Pipitone, E., Vitolo, M., Raparelli, V., Basili, S., Boriani, G., Harari, S., Lip, G. Y. H., & Proietti, M. (2021). Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. European Heart Journal, 42(35), 3541–3554. https://doi.org/10.1093/eurheartj/ehab453

Chicago

Romiti, Giulio Francesco, Bernadette Corica, Eugenia Pipitone, Marco Vitolo, Valeria Raparelli, Stefania Basili, Giuseppe Boriani, Sergio Harari, Gregory Y H Lip, and Marco Proietti. 2021. “Prevalence, Management and Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,200,000 Patients.” European Heart Journal 42 (35): 3541–54. doi:10.1093/eurheartj/ehab453.